No Picture
Trading Ideas

UPDATE 1-Abbott CEO Miles White to step down next year

Abbott Laboratories Chief Executive Officer Miles White will step down next year after leading the healthcare conglomerate for more than two decades. White, who will remain the executive chairman, will be succeeded by Chief Operating Officer Robert Ford, the company said on Wednesday. White, 64, was instrumental in Abbott’s acquisitions of rivals St. Jude Medical and Alere, as well as the separation of Abbott’s pharmaceutical arm into AbbVie Inc. …read more […]

No Picture
Trading Ideas

UPDATE 1-Vertex deal with Wales expands cystic fibrosis treatment coverage to all of UK

Vertex Pharmaceuticals Inc’s drugs for lung condition cystic fibrosis will now be available to patients across the UK after the company reached a pricing deal with Wales on Wednesday. The U.S. drugmaker has already reached similar agreements with the National Health Service in Northern Ireland, England and Scotland. More than 10,000 people in Britain have cystic fibrosis, a debilitating, life-shortening inherited condition, making it the country with the second highest number of such patients in the world, according to the company. …read more […]

No Picture
Trading Ideas

UPDATE 1-ADM says to focus on organic growth after acquisitions

Grain trader Archer Daniels Midland Co ADM does not expect to continue its aggressive strategy of acquisitions in the next few years and will instead focus on organic growth, a senior official said on Wednesday. “With this level of acquisitions we have had, I don’t think you will see ADM being a very aggressive M&A investor over the next few years,” Ismael Roig, Europe, Middle East and Africa President Archer Daniels Midland Co told the Global Grain conference in Geneva. …read more […]